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Summary. The mechanisms of antimicrobial resistance were characterized in 90 Salmonella enterica isolates either resist-
ant or with intermediate resistance to amoxicillin/clavulanate (AMCR/I) or resistant to third-generation cephalosporins (C3GR).
These isolates were recovered in three Spanish hospitals during 2007–2009. The C3GR phenotype was expressed by three iso-
lates that carried the following extended-spectrum β-lactamase genes: phage-associated blaCTX M-10 in S. Virchow, blaCTX-M-14a
surrounded by ISEcp1 and IS903 in S. Enteritidis, and blaCTX-M-15 linked to ISEcp1 and orf477 in S. Gnesta (first description
in this serotype). The AMCR/I phenotype was found in 87 isolates (79 S. Typhimurim, 7 S. Enteritidis, and one S. Thompson).
The blaPSE-1 gene, followed by blaOXA-1 was mostly found among S. Typhimurim, and the blaTEM-1 gene among S. Enteritidis.
Three different gene combinations [blaPSE-1+floR+aadA2+sul+tet(G); blaOXA-1+catA+aadA1/strA-strB+sul+tet(B) and blaTEM-1+
cmlA1+aadA/strA-strB+sul+tet(A)/tet(B) genes] were associated with the ampicillin-chloramphenicol-streptomycin-sulfon-
amides-tetracycline phenotype in 68 AMCR/I S. enterica isolates. Class 1 integrons were observed in 79% of the isolates and
in most of them (45 isolates) two integrons including the aadA2 and blaPSE-1 gene cassettes, respectively, were detected. The
blaOXA-1+aadA1 arrangement was detected in 23 isolates, and the aac(6′)-Ib-cr+blaOXA-1+catB3+arr3 in another one. Non-classic
class 1 integrons were found in three isolates: dfrA12+orfF+aadA2+cmlA1+aadA1 (1 isolate), dfrA12+orfF+aadA2+
cmlA1+aadA1+qacH+IS440+sul3 (1 isolate) and dfrA12+orfF+aadA2+cmlA1+aadA1+qacH+IS440+ sul3+orf1+mef(B)Δ-IS26
(1 isolate). Taken together, these results underline the need for clinical concern regarding β-lactam resistance in Salmonella
and thus for continuous monitoring. [Int Microbiol 2011; 14(3):173-181]
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Introduction 
Salmonella enterica is the second most frequent cause of
zoonotic diseases in humans in Europe, and more than
150,000 cases of human salmonellosis were reported by The
European Surveillance System during 2007 [8]. Salmonella
Enteritidis and Salmonella Typhimurium are two of the ten
most common serotypes confirmed in salmonellosis cases in
humans, representing 81% of the isolates [8]. S. Typhi-
murium is frequently associated with multidrug resistance
[3,26], in part due to the worldwide emergence of S. Typhi-
murium definitive phage type (DT) 104, which contains the
chromosomal Salmonella genomic island type I (SGI-1).
SGI-1 harbors genes that confer the ACSSuT phenotype (i.e.,
resistance to ampicillin, chloramphenicol, streptomycin, sul-
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fonamides, and tetracycline) [16]. Although S. Typhimurium
DT104 is the main example of multiresistance in S. enterica,
many antimicrobial resistance genes have been reported also
in isolates of other serotypes [14]. 
Non-typhoidal Salmonella infections generally result in
mild-to-moderate self-limiting gastroenteritis, and antimi-
crobial treatment is only required in severe cases occurring
in vulnerable patient groups or to combat invasive infec-
tions. However, due to the increasing resistance of this bac-
terium to the conventional antimicrobial agents (ampicillin,
and trimethoprim/sulfamethoxazole) used in the treatment
of salmonellosis, amoxicillin/clavulanate, third-generation
cephalosporins, and fluoroquinolones have become further
treatment options. Resistance to β-lactams in S. enterica is
mainly due to the production of acquired β-lactamases [14].
Among these, TEM-1, PSE-1, and OXA-1 have been
described as the enzymes most frequently related to ampi-
cillin and amoxicillin/clavulanate resistance [3,11]. The
resistance of Salmonella to third-generation cephalosporins
is primarily mediated by the production of extended-spec-
trum β-lactamases (ESBL) of the TEM, SHV, and CTX-M
types, which are associated with different mobile genetic
elements [11,14]. ESBL have been described not only in
clinical Salmonella isolates but also in isolates from animals
and food [6,21].
Mobile genetic elements such as plasmids and trans-
posons, possibly containing integrons, are able to dissemi-
nate antimicrobial resistance by horizontal transfer in
Enterobacteriaceae. Integrons are genetic elements that cap-
ture and incorporate gene cassettes by using a site-specific
recombination mechanism [4]. Thus far, class 1 and, less fre-
quently, class 2 integrons have been reported for S. enterica
[4]. Class 1 integrons contain a 5′-conserved segment (5′-CS)
that includes the integrase intI1 gene, the attI1 recombination
site, and the Pc promoter. It is followed by a variable region
where one or more gene cassettes are located. This class of
integrons also contains a 3′-conserved segment (3′-CS) that
includes the sul1 and qacEΔ1 genes, which encode resistance
to sulfonamides and ammonium quaternary compounds,
respectively [4].
In recent years, resistance to amoxicillin/clavulanate
among S. enterica isolated from different Spanish hospitals
has become increasingly widespread, accompanied by the
emergence of ESBL-producing isolates, detected in human
samples. Consequently, there are fewer therapeutic options
for the treatment of S. enterica infections, placing these
patients at greater risk of serious morbidity and even death.
The aim of the present work was to characterize the mecha-
nisms of resistance to β-lactams and other antimicrobial
agents as well as the integrons in all amoxicillin/clavulanate-
resistant, intermediately resistant (AMCR/I), and third-gener-
ation cephalosporin-resistant (C3GR) S. enterica isolates
recovered in three Spanish hospitals during the period
2007–2009. 
Materials and methods
Isolates and antimicrobial susceptibility testing. In this
study, 90 S. enterica isolates with the AMCR/I phenotype (87 isolates) or the
C3GR phenotype (3 isolates) were recovered in three Spanish hospitals locat-
ed in geographically distinct areas: Hospital General Universitario Gregorio
Marañón of Madrid (HGM, 39 isolates), Hospital San Pedro of Logroño
(HSP, 36 isolates), and Complejo Hospitalario of Pontevedra (CHP, 15 iso-
lates). AMCR/I and C3GR phenotypes were detected in 12–23% and <1%,
respectively, of all S. enterica isolated in the three hospitals. The 90 isolates
were recovered from fecal (73 isolates), blood (2 isolates), urine (1 isolate)
and other (14 isolates) samples from different patients during 2007 (29 iso-
lates), 2008 (34 isolates), and 2009 (27 isolates). The serotypes of these iso-
lates were as follows: S. Typhimurium (79 isolates), S. Enteritidis (8 isolates,
one of them C3GR), S. Virchow (1 isolate, C3GR), S. Gnesta (1 isolate,
C3GR), and S. Thompson (1 isolate).
Susceptibility testing to 20 antimicrobial agents (ampicillin, AMC,
cefalotin, cefazolin, ceftazidime, cefotaxime, aztreonam, cefoxitin, gentam-
icin, tobramycin, kanamycin, amikacin, streptomycin, nalidixic acid,
ciprofloxacin, tetracycline, chloramphenicol, sulfonamides, trimethoprim,
trimethoprim/sulfamethoxazole) was performed by the disc-diffusion [5]
and microdilution methods (MicroScan Combo Neg panels, Siemens,
Sacramento, CA, USA) according to the Clinical and Laboratory Standards
Institute (CLSI) guidelines. The AmpC phenotype was determined by com-
parison of the inhibition zone of cefoxitin discs (30 μg) in the presence or
absence of cloxacillin (200 μg) [29]. The ESBL phenotype was determined
using the double-disc synergy test with cefotaxime, ceftazidime, and aztre-
onam discs placed in the proximity of the AMC disc [13].
Detection of antimicrobial resistance genes. The presence of
genes implicated in the resistance to β-lactams (blaTEM, blaSHV, blaCTX-M,
blaOXA-1 and blaPSE-1), and the blaCTX-M genetic environment was detected by
PCR and sequencing [7,17,31]. In addition, multiplex PCR for the detection
of plasmidic AmpC-type β-lactamases was carried out [20].
Tetracycline [tet(A)-tet(E),tet(G)], aminoglycoside [aadA, strA-strB,
aac(3)-I, aac(3)-II, aac(3)-IV, ant(2′′), aph(3′)-Ia, aph(3′)-IIa, rmtB, armA
and aac(6′)-Ib], sulfonamides [sul1, sul2 and sul3], trimethoprim [dfrA],
chloramphenicol [cmlA, catA and floR], and quinolone [qnrA, qnrB, qnrS
and qepA] resistance genes were studied by PCR and sequencing [7,24,27].
The genetic enviroments of the sul1, sul2, and sul3 genes were determined
as previously reported [32].
Detection and characterization of integrons. The presence of
class 1, 2, and 3 integrase-encoding genes and of the 3′-CS of class 1 inte-
grons, qacEΔ1+sul1, was analyzed by PCR. The variable regions of these
integrons were PCR-amplified and subsequently sequenced to determine
their gene cassette arrangements [24].
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Results
Antimicrobial susceptibility in Salmonella
enterica isolates. Table 1 shows the antimicrobial sus-
ceptibility of the 90 AMCR/I or C3GR S. enterica isolates
included in this study. The S. Typhimurium isolates were
highly resistant to sulfonamides (100%), tetracycline (91%),
chloramphenicol (86%), and streptomycin (80%). Aminogly-
cosides resistance was found only among isolates of serotype
S. Typhimurium. All isolates studied were susceptible to
amikacin, cefoxitin and ciprofloxacin. A multiresistant phe-
notype (resistant to at least three different antimicrobial agent
families) was observed among 100% of the S. Typhimurium
and 12.5% of the S. Enteritidis isolates. Two S. Typhimurium
isolates had a heptaresistant phenotype that included the
ACSSuT phenotype in addition to resistance to trimethoprim
and gentamicin or nalidixic acid (ACGSSuTTm and
ACSSuTTmN, respectively).
The AmpC phenotype was not identified among the iso-
lates tested. However, the ESBL phenotype was determined in
three of them and corresponded to one isolate each of S. Ente-
rica, S. Virchow, and S. Gnesta serotypes (Table 1). All three
were resistant to cefotaxime, while S. Gnesta isolate was also
resistant to ceftazidime and aztreonam. 
Antimicrobial resistance genes. Tables 2 and 3 list
the resistance genes detected in the 90 S. enterica isolates,
according to serotype. The most frequent β-lactamase gene
identified among the AMCR/I isolates was blaPSE-1, detected in
ANTIBIOTIC RESISTANCE IN S. ENTERICA
Table 1. Number of AMCR/I or C3GR of Salmonella enterica isolates resistant to antimicrobial agents. The isolates were of different serotypes and obtained
from three Spanish hospitals
Antimicrobial agenta S. Typhimurium 
(n = 79)
S. Enteritidis 
(n = 8)
S. Virchow 
(n = 1)
S. Gnesta 
(n = 1)
S. Thompson 
(n = 1)
All S. enterica
tested (n = 90)
AMCb 79 7 0 0 1 87 
Cefalotin 7 1 1 1 0 10
Cefazolin 9 1 1 1 0 12
Ceftazidime 0 0 0 1 0 1
Cefotaxime 0 1 1 1 0 3 
Aztreonam 0 0 0 1 0 1 
Gentamicin 1 0 0 0 0 1
Tobramycin 1 0 0 0 0 1
Kanamycin 2 0 0 0 0 2
Streptomycin 63 0 0 0 0 63 
Nalidixic acid 17 2 1 0 0 20
Tetracycline 72 1 1 0 1 75
Chloramphenicol 68 0 0 0 1 69
Sulfonamides 79 3 1 1 1 85
Trimethoprim 5 0 0 0 0 5 
SXTc 5 1 0 0 0 6 
ESBL phenotype 0 1 1 1 0 3
aAll the isolates were resistant to ampicillin, but susceptible to cefoxitin, amikacin, and ciprofloxacin. 
bAMC: Amoxicillin/clavulanate.
cSXT: Trimethoprim-sulfamethoxazole.
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Table 2. Antimicrobial resistance genes and the resistance phenotype of Salmonella enterica isolates from three Spanish hospitals
Number of resistant isolates Resistance genes S. Typhimurium S. Enteritidis Other serotypes Total (n = 90)
β-Lactams (n = 90) blaPSE-1 41 – – 41
blaOXA-1 23 – 1 24
blaTEM-1b 9 6 – 15
blaTEM-1c 1 – – 1
3blaPSE-1 + blaOXA-1 1 – – 1
blaPSE-1 + blaTEM-1b 3 – – 3
blaCTX-M-10 – – 1 1
blaCTX-M-14a – 1 – 1
blaCTX-M-15 + blaTEM-1c – – 1 1
No studied bla genes 1 1 – 2
Tetracyclinea (n = 82) tet(A) 5 – – 5
tet(B) 29 – 1 30
tet(G) 45 – – 45
No studied tet genes – 1 1 2
Streptomycinb (n = 76) aadA1/aadA2 66 – – 66
strA-strB 5 – – 5
aadA1/aadA2+strA-strB 4 – – 4
No studied genes 1 – – 1
Gentamicin (n = 1) aac(3)-IV 1 – – 1
Kanamycin (n = 2) aph(3′)-Ia 1 – – 1
No studied genes 1 – – 1
Chloramphenicol (n = 69) floR 44 – 1 45
catA 18 – – 18 
cmlA1 3 – – 3
floR + catA 2 – – 2 
floR + cmlA 1 – – 1
Sulfonamides (n = 85) sul1 54 – – 54
sul2 8 – 1 9
sul1 + sul2 14 – 1 15
sul2 + sul3 1 – – 1
sul1+ sul2 + sul3 1 – – 1
No studied sul genes 1 3 1 5
Trimethoprim (n = 5) dfrA12 3 – – 3
dfrA14 2 – – 2
aSeven of the studied isolates with a phenotype of intermediate resistance to tetracycline harbored the tet(G) gene. 
bTwelve of the studied isolates with a phenotype of intermediate resistance to streptomycin harbored the aadA1/aadA2 gene. Three of the isolates with a sus-
ceptibility to streptomycin harbored strA-strB genes. 
cblaTEM-1 variant showed a silent nucleotide change (T→C) at position 735 [28].
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51.7% of the 87 AMCR/I isolates including all those belong-
ing to S. Typhimurim. In addition, the gene was associated
with other bla genes in four of these isolates (blaTEM-1b or
blaOXA-1). The blaOXA-1 gene was identified in 27.6% of the
AMCR/I isolates (23 S. Typhimurium and 1 S. Thompson),
and only in one case in association with other bla genes. In
addition, the blaTEM-1 gene was demonstrated in 21.8% of the
AMCR/I isolates (13 S. Typhimurium and 6 S. Enteritidis) and
associated with other bla genes in three of them. As shown in
Table 2, blaTEM-1 was the most frequent bla gene in S. Enteri-
tidis isolates.
The β-lactamase genes identified among the three C3GR
isolates with an ESBL-positive phenotype were as follows:
blaCTX-M-14a (S. Enteritidis), blaCTX-M-15 (S. Gnesta), and blaCTX-M-10
(S. Virchow). In these isolates, the ISEcp1-blaCTX-M-14a-IS903
and ISEcp1-blaCTX-M-15-orf477 structures were identified. The
blaCTX-M-15-positive S. Gnesta isolate also carried a new vari-
ant of the blaTEM-1 β-lactamase gene that showed a silent
nucleotide change (T→C) at position 735 according to the
Sutcliffe nomenclature [28]. Regarding the blaCTX-M-10 genetic
environment, the gene’s upstream region included a group of
ORFs (orf2, orf3 and orf4) and a phage-related DNA inver-
tase. Downstream, orf7 was identified. All of the S. enterica
isolates tested were negative for the plasmid-mediated
quinolone resistance genes qnrA, qnrB, qnrS, and qepA.
Integron detection and characterization.
Seventy-one of the 90 isolates (79%) were positive for the
intI1 gene, and six different gene cassette arrangements were
determined (Table 3, Fig.1). Class 2 and 3 integrons were
absent. All 45 blaPSE-1-positive S. Typhimurium isolates
showed two integrons, with variable regions of 1000 and
1200 bp, harboring the aadA2 and blaPSE-1 gene cassettes,
respectively. The blaOXA-1 + aadA1 gene array was found in
most of the blaOXA-1-positive isolates (23 of 25), whereas the
S. Thompson isolate  showed the aac(6′)-Ib-cr+blaOXA-1+catB3
+arr3 arrangement.  Three non-classic class 1 integrons (lack-
ing the 3′-CS) were found in three isolates (Fig. 1). 
Genetic environment of sul genes. Of the 90 S. ente-
rica isolates studied, 94.4% were resistant to sulfonamides.
At least one sul gene was detected in 80 of them, and more
than one sul gene in 17 of them (Table 2). The sul1 gene was
associated with class 1 integrons in all 70 sul1-positive iso-
lates (Table 3). 
The genetic environment of the sul2 gene was determined
in 11 of the 26 sul2-positive S. enterica isolates (42.3%).
Four different structures were demonstrated (number of iso-
lates): repC+sul2+strA-strB+tnpB (6), repC+sul2+strA-
strB+IS26 (2), repC+sul2+strA-strB (1) and sul2 +strAΔdfrA14
-strB (2). In these two last isolates, the strA gene was truncated
by the dfrA14 gene, and a streptomycin-susceptibility pheno-
type was determined in both isolates. The sul3 gene was
associated with the above mentioned non-classic class 1 inte-
grons (lacking the 3′-CS) in the two sul3-positive isolates. 
In summary, an ACSSuT phenotype (including intermedi-
ate resistance) was confirmed in 68 S. enterica isolates (all of
them Typhimurium), 15 of which were additionally resistant
to nalidixic acid and three others to trimethoprim (Table 3).
Three general gene profiles were mostly responsible for the
ACSSuT multiresistant phenotype: (i) The blaPSE-1 and aadA2
genes, located within two class 1 integrons (structure A, Fig. 1),
were associated with the floR, sul and tet(G) genes in 45 of
these isolates. In five of the 45 isolates, one non-classic class 1
integron (dfrA12+orfF+aadA2+cmlA1+aadA1), the blaTEM-1
gene, and the blaOXA-1 gene were additionally detected (one,
three, and one isolate, respectively). (ii) The blaOXA-1 and
aadA1 (located within a class 1 integron of structure B, Fig. 1),
catA, sul, and tet(B) gene profile occurred in 20 isolates. The
floR gene was additionally found in two of them. (iii) An
association between blaTEM-1b, cmlA1, aadA or strA-strB, sul,
and tet(A) or tet(B) genes was detected in three isolates. In
one of them, the aac(3)-IV and dfrA12 genes were addition-
ally amplified, confirming this S. Typhimurium isolate’s
ACGSSuTTm phenotype (Table 3).
Discussion
Antimicrobial resistance in S. enterica is a cause of serious
concern in human medicine. The drugs of choice for the
treatment of complicated salmonellosis are usually ampi-
cillin, amoxicillin/clavulanate, third-generation cephalos-
porins, or fluoroquinolones, but the increasing emergence of
resistance to these antimicrobials limits the therapeutic
choices [9,15,18]. In our study, the AMCR/I phenotype was
detected in 12–23% of all S. enterica isolates recovered
from human samples obtained from three Spanish hospitals.
The β-lactamase-related mechanisms implicated in this
AMCR/I phenotype were the production of the enzymes PSE-1,
OXA-1 and TEM-1, as previously reported in other series
[11]. The high prevalence of blaPSE-1 and blaTEM-1 observed
among S. Typhimurium and S. Enteritidis isolates, respec-
tively, was also previously reported [3,11,26]. The detection
of more than one β-lactamase gene in the same isolate was
infrequent in our study (4 isolates), in contrast to the data
from other studies [3,11].
ANTIBIOTIC RESISTANCE IN S. ENTERICA
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Table 3. Phenotypes and mechanisms of resistance detected in the 90 AMCR/I and C3GR Salmonella enterica isolates
Phenotype of resistance (number of isolates)a,b Genotype of resistance (number of isolates)c Class 1
integrond
S. Typhimurium (n = 79) SUL+TET (1) blaTEM-1c + sul2 + tet(B) (1) –
STR+SUL+TET (7) blaOXA-1 + aadA + sul1 + tet(B) (2)
blaTEM-1b + strA-strB + sul2 + tet(B) (3)
blaTEM-1b + strA-strB + sul2 + tet(A) (1)
tet(B) (1)
(B)
–
–
–
STR+SUL+TET+NAL (1) blaOXA-1 + aadA + sul1+ tet(B) (1) (B)
SUL+TET+TMP+SXT (1) blaTEM-1b + strAΔdfrA14-strB + sul2+ tet(A) (1) –
CHL+STR+SUL+TET+KAN (2) blaPSE-1 + blaOXA-1 + floR + aadA + sul1+ tet(G) (1)
blaPSE-1 + floR + aadA + sul1 + tet(G) + aph(3′)-Ia (1)
(A)
(A)
CHL+STR+SUL+TET+NAL (14)f blaPSE-1 + floR + aadA + sul1 + tet(G) (10)
blaOXA-1 + floR + catA + aadA + sul1 + tet(B) (1)
blaOXA-1 + catA + aadA + sul1 + tet(B) (3)
(A)
(B)
(B)
SUL+TET+TMP+SXT+NAL (1) blaTEM-1b + sul2 + tet(A) + strAΔdfrA14- strB – 
CHL+STR+SUL+TET+TMP+SXT (1) blaTEM-1b + cmlA1 + aadA + strA-strB + sul2 + sul3 + tet(A)
+ dfrA12
(E)
CHL+STR+SUL+TET+TMP+SXT+NAL (1) blaPSE-1 + floR + cmlA1 + aadA + sul1 + tet(G) + dfrA12 (A)+(D)
CHL+STR+SUL+TET+GEN+TOB+TMP+SXT (1) blaTEM-1b + cmlA1 + aadA + sul1 + sul2 + sul3 + tet(A) +
aac(3)-IV + dfrA12
(F)g
S. Enteritidis (n = 8) None (2) blaTEM-1b –
NAL (1) – (1) –
TET (1) blaTEM-1b –
SUL (2) blaTEM-1b –
CTX+NAL (1) blaCTX-M-14a –
SUL+SXT (1) blaTEM–1b –
S. Gnesta (n = 1) ATM+CAZ+CTX+SUL (1) blaCTX-M-15 + blaTEM-1 –
S. Thompson (n = 1) CHL+SUL+TET (1) blaOXA-1 + floR + catB3 + sul1+ sul2 + aac(6′)-Ib-cr (C)
S. Virchow (n = 1) SUL+TET+CTX+NAL (1) blaCTX-M-10 + sul2 + tet(B) + strA-strB –
aAbbreviations: CAZ: ceftazidime, CTX: cefotaxime, ATM: aztreonam, GEN: gentamicin, TOB: tobramycin, KAN: kanamycin, STR: streptomycin, NAL: nalidixic
acid,  TET: tetracycline, CHL: chloramphenicol, SUL: sulfonamides, TMP: trimethoprim, SXT: trimethoprim/sulfamethoxazole.
bACSSuT phenotype is marked in bold letters.
cStreptomycin resistance genes aadA correspond to aadA1 or aadA2.
dIntegron structures A-F correspond to those shown in Fig. 1. 
eSix of these isolates had an intermediate phenotype with respect to tetracycline and nine isolates with respect to streptomycin. 
fOne of these isolates had an intermediate phenotype with respect to tetracycline and two with respect to streptomycin.
gThis integron contained the putative macrolide efflux gene mef(B), truncated by IS26 such that only 256 bp of mef(B) remained.
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The ESBL phenotype in human clinical isolates of S. ente-
rica is of particular interest but in our study it was detected in
<1% of the S. enterica isolates obtained from the three hos-
pitals. ESBL are spreading very rapidly among E. coli and
Klebsiella spp. isolates whereas their frequency among S. ente-
rica isolates is much lower [2,15,18]. The diversity of ESBL
detected among our three ESBL-positive S. enterica isolates
(CTX-M-14, CTX-M-15, and CTX-M-10) is noteworthy as
is the fact that these genes were identified in unusual
serotypes, i.e., S. Gnesta and S. Virchow.
The CTX-M-14 β-lactamase-encoding gene, flanked by
ISEcp1 and IS903 sequences, has been frequently detected in
E. coli isolates of human and animal origin in Spain [6]. In
S. enterica, the first description of this enzyme, in a clinical
isolate of S. Enteritidis recovered in Spain, was that of
Romero et al. [23]. However, the blaCTX-M-14 gene has been
identified in Salmonella of different serotypes and in several
countries [2,6,9,18]. The genetic element ISEcp1 is a mobile
and mobilizing element that may be implicated in the blaCTX-
M-14 gene mobilization [19]. Similarly, the blaCTX-M-15 gene,
flanked by ISEcp1 and orf477 elements, has been shown to
be disseminated throughout the world and is mostly detect-
ed among E. coli and Klebsiella isolates [6]. In our study, this
enzyme was identified in a S. Gnesta isolate. To our knowledge,
this is the first description of the presence of the CTX-M-15
β-lactamase in S. Gnesta, a serotype uncommonly associated
with human salmonellosis.
The CTX-M-10 enzyme has been described in E. coli,
Enterobacter spp., Klebsiella spp., and S. Virchow isolates in
Spain [6,9,17,21]. In the present work, this enzyme was also
found in a S. Virchow isolate, and the genetic environment of
the blaCTX-M-10 gene was associated with a phage-related ele-
ment, similar to one previously reported [17,21].
The ACSSuT multiresistance phenotype was detected in
68 of the S. Typhimurium isolates. Although this phenotype
is usually associated with the widely distributed chromoso-
mal SGI-1 (contains the blaPSE-1, floR, aadA2, sul, and tet(G)
genes) [16,30], other gene profiles have also been described
[10,12,22]. Indeed, in our study different resistant genotypes
were determined; the most common one was the SGI-1
linked profile. The association of the blaOXA-1, catA, [aadA1 /
strA-strB], sul, and tet(B) genes, with the blaOXA-1+aadA1
arrangement included within a 2000-bp class 1 integron, was
found among 20 S. Typhimurium ACSSuT-resistant isolates.
In addition, the gene profile blaTEM-1, cmlA1, [aadA / strA-
strB], sul and [tet(A) / tet(B)] was identified in three S. Typhi-
murium isolates. In previous studies, these latter two resist-
ance-gene profiles were shown to be located on hybrid self-
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Fig. 1. Gene cassette arrangements among class 1 integrons detected in Salmonella enterica isolates.
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transferable plasmids, which also contain virulence genes,
such as the pUO-StVR plasmids in S. Typhimurium and the
recently reported pUO-SeVR1 in S. Enteritidis [10,12,22].
Further studies of our isolates are needed to determine the
plasmid localization of these ACSSuT resistance genes
and/or their possible association with virulence genes.
Class 1 integrons were present in 79% of the 90 isolates
tested. Note the presence of a class 1 integron with the aac(6′)
-Ib-cr+blaOXA-1+catB3+arr3 structure in the S. Thompson iso-
late. While this arrangement has been previously described, it
is usually associated with complex integrons containing the
ISCR1 elements, double copies of 3′-CS, and qnr genes,
among others (e.g., GenBank accession numbers AJ971343
and AY259086). In addition, non-classical integrons (without
qacEΔ1+sul1 genes) were found in three isolates (4%). All
three included the gene cassette organization dfrA12+orfF
+aadA2+cmlA1+aadA1, in two of these three isolates in
association with the qacH+IS440+sul3 structure previously
reported in Salmonella and E. coli [1,25].
In conclusion, blaPSE-1 and blaOXA-1 were the most frequent
bla genes implicated in the AMCR/I phenotype in S. Typhimu-
rium, and blaTEM-1 the most frequent in S. Enteritidis. ESBL-
positive isolates, corresponding to non-S. Typhimurium
serotypes, were identified in <1% of the S. enterica isolates
obtained from the three hospitals. Among the three different
ESBL variants detected, ours is the first description of CTX-
M-15 in S. Gnesta. In addition, the frequent association of
the β-lactamase production with nalidixic acid resistance
(22%), which precludes the use of fluoroquinolones in the
treatment of salmonellosis, is a cause for clinical concern and
underlines the need to track the evolution of β-lactamases in
S. enterica isolates.
Acknowledgements. We thank M. Aurora Echeita from the Centro
Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain, for
serotyping of the isolates. M. de T. is the recipient of a predoctoral fellow-
ship from the Instituto de Salud Carlos III of Spain (MINCINN) (grant num-
ber FI08/00506). 
Competing interests. None declared.
References 
1. Antunes P, Machado J, Peixe L (2007) Dissemination of sul3-containing
elements linked to class 1 integrons with an unusual 3′ conserved
sequence region among Salmonella isolates. Antimicrob Agents
Chemother 51:1545-1548 
2. Arlet G, Barrett TJ, Butaye P, Cloeckaert A, Mulvey MR, White DG
(2006) Salmonella resistant to extended-spectrum cephalosporins:
prevalence and epidemiology. Microbes Infect 8:1945-1954 
3. Biendo M, Laurans G, Thomas D, Canarelli B, Hamdad-Daoudi F,
Rousseau F, Castelain S, Eb F (2005) Molecular characterisation and
mechanisms of resistance of multidrug-resistant human Salmonella
enterica serovar Typhimurium isolated in Amiens (France). Int J Anti-
microb Agents 26: 219-229 
4. Cambray G, Guerout AM, Mazel D (2010) Integrons. Annu Rev Genet
44:141-166 
5. Clinical and Laboratory Standards Institute (2010) Performance stan-
dards for antimicrobial susceptibility testing: Eighteenth informational
supplement M100-S20. CLSI, Wayne, PA, USA
6. Coque TM, Baquero F, Cantón R (2008) Increasing prevalence of
ESBL-producing Enterobacteriaceae in Europe. Euro Surveill
13:19044 
7. de Toro M, Rojo-Bezares B, Vinué L, Undabeitia E, Torres C, Sáenz Y
(2010) In vivo selection of a aac(6′)-Ib-cr and mutations in the gyrA
gene in a clinical qnrS1-positive Salmonella enterica serovar
Typhimurium DT104B strain recovered after fluoroquinolone treat-
ment. J Antimicrob Chemother 65:1945-1949 
8. European Food Safety Authority (EFSA) (2009) The Community sum-
mary report on trends and sources of zoonoses and zoonotic agents in
the European Union in 2007. EFSA J 223 
9. González-Sanz R, Herrera-León S, de la Fuente M, Arroyo M, Echeita
MA (2009) Emergence of extended-spectrum β-lactamases and AmpC-
type β-lactamases in human Salmonella isolated in Spain from 2001 to
2005. J Antimicrob Chemother 64:1181-1186 
10. Guerra B, Soto S, Helmuth R, Mendoza MC (2002) Characterization of
a self-transferable plasmid from Salmonella enterica serotype Typhi-
murium clinical isolates carrying two integron-borne gene cassettes
together with virulence and drug resistance genes. Antimicrob Agents
Chemother 46:2977-2981 
11. Güerri ML, Aladueña A, Echeita A, Rotger R (2004) Detection of inte-
grons and antibiotic-resistance genes in Salmonella enterica serovar
Typhimurium isolates with resistance to ampicillin and variable suscep-
tibility to amoxicillin-clavulanate. Int J Antimicrob Agents 24:327-333 
12. Herrero A, Mendoza MC, Threlfall EJ, Rodicio MR (2009) Detection of
Salmonella enterica serovar Typhimurium with pUO-StVR2-like viru-
lence-resistance hybrid plasmids in the United Kingdom. Eur J Clin
Microbiol Infect Dis 28:1087-1093 
13. Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-
spectrum β-lactamases conferring transferable resistance to newer β-
lactam agents in Enterobacteriaceae: hospital prevalence and suscepti-
bility patterns. Rev Infect Dis 10:867-878 
14. Michael GB, Butaye P, Cloeckaert A, Schwarz S (2006) Genes and
mutations conferring antimicrobial resistance in Salmonella: an update.
Microbes Infect 8:1898-1914 
15. Miriagou V, Tassios PT, Legakis NJ, Tzouvelekis LS (2004) Expanded-
spectrum cephalosporin resistance in non-typhoid Salmonella. Int J
Antimicrob Agents 23:547-555 
16. Mulvey MR, Boyd DA, Olson AB, Doublet B, Cloeckaert A (2006) The
genetics of Salmonella genomic island 1. Microbes Infect 8:1915-1922 
17. Oliver A, Coque TM, Alonso D, Valverde A, Baquero F, Cantón R (2005)
CTX-M-10 linked to a phage-related element is widely disseminated
among Enterobacteriaceae in a Spanish hospital. Antimicrob Agents
Chemother 49:1567-1571 
18. Pardos de la Gándara M, Seral C, Castillo García J, Rubio Calvo C,
Weill FX (2011) Prevalence and characterization of extended-spectrum
beta-lactamases-producing Salmonella enterica isolates in Saragossa,
Spain (2001-2008) Microb Drug Resist 17:207-213
DE TORO  ET AL.
181INT. MICROBIOL. Vol.14, 2011
19. Partridge SR (2011) Analysis of antibiotic resistance regions in Gram-
negative bacteria. FEMS Microbiol Rev 35:820-855 
20. Pérez-Pérez FJ, Hanson ND (2002) Detection of plasmid-mediated
AmpC β-lactamase genes in clinical isolates by using multiplex PCR.
J Clin Microbiol 40:2153-2162
21. Riaño I, García-Campello M, Sáenz Y, Álvarez P, Vinué L, Lantero M,
Moreno MA, Zarazaga M, Torres C (2009) Occurrence of extended-
spectrum β-lactamase-producing Salmonella enterica in northern Spain
with evidence of CTX-M-9 clonal spread among animals and humans.
Clin Microbiol Infect 15:292-295
22. Rodríguez I, Guerra B, Mendoza MC, Rodicio MR (2011) pUO-SeVR1
is an emergent virulence-resistance complex plasmid of Salmonella
enterica serovar Enteritidis. J Antimicrob Chemother 66:218-220
23. Romero L, López L, Martínez-Martínez L, Guerra B, Hernández JR,
Pascual A (2004) Characterization of the first CTX-M-14-producing
Salmonella enterica serotype Enteritidis isolate. J Antimicrob
Chemother 53:1113-1114 
24. Sáenz Y, Briñas L, Domínguez E, Ruiz J, Zarazaga M, Vila J, Torres C
(2004) Mechanisms of resistance in multiple-antibiotic-resistant
Escherichia coli strains of human, animal, and food origins. Antimicrob
Agents Chemother 48:3996-4001 
25. Sáenz Y, Vinué L, Ruiz E, Somalo S, Martínez S, Rojo-Bezares B,
Zarazaga M, Torres C (2010) Class 1 integrons lacking qacEDelta1 and
sul1 genes in Escherichia coli isolates of food, animal and human ori-
gins. Vet Microbiol 144:493-497 
26. Soto SM, González-Hevia MA, Mendoza MC (2003) Antimicrobial
resistance in clinical isolates of Salmonella enterica serotype Enteri-
tidis: relationships between mutations conferring quinolone resistance,
integrons, plasmids and genetic types. J Antimicrob Chemother 51:
1287-1291
27. Sunde M, Norström M (2006) The prevalence of, associations between
and conjugal transfer of antibiotic resistance genes in Escherichia coli
isolated from Norwegian meat and meat products. J Antimicrob
Chemother 58:741-747 
28. Sutcliffe JG (1978) Nucleotide sequence of the ampicillin resistance
gene of Escherichia coli plasmid pBR322. Proc Natl Acad Sci USA
75:3737-3741 
29. Tan TY, Ng LS, He J, Koh TH, Hsu LY (2009) Evaluation of screening
methods to detect plasmid-mediated AmpC in Escherichia coli, Kleb-
siella pneumoniae and Proteus mirabilis. Antimicrob Agents Chemother
53:146-149
30. Targant H, Ponsin C, Brunet C, Doublet B, Cloeckaert A, Madec JY,
Meunier D (2010) Characterization of resistance genes in multidrug-
resistant Salmonella enterica serotype Typhimurium isolated from dise-
ased cattle in France (2002 to 2007). Foodborne Pathog Dis 7:419-425 
31. Vinué L, Lantero M, Sáenz Y, Somalo S, de Diego I, Pérez F, Ruiz-
Larrea F, Zarazaga M, Torres C (2008) Characterization of extended-
spectrum β-lactamases and integrons in Escherichia coli isolates in a
Spanish hospital. J Med Microbiol 57:916-920 
32. Vinué L, Sáenz Y, Rojo-Bezares B, Olarte I, Undabeitia E, Somalo S,
Zarazaga M, Torres C (2010) Genetic environment of sul genes and cha-
racterisation of integrons in Escherichia coli isolates of blood origin in
a Spanish hospital. Int J Antimicrob Agents 35:492-496
ANTIBIOTIC RESISTANCE IN S. ENTERICA
